Editas Medicine suspends ATM offering program; $43.9M raised to date

Editas Medicine, Inc.

Notified TD Cowen of suspension and termination of March 21, 2025 prospectus supplement.
No further ATM sales until new prospectus or registration statement is filed and effective.
Sales Agreement with TD Cowen remains in full force and effect.
Aggregate sales to date: 14,327,365 shares for $43.9M gross proceeds before expenses.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.